Global Picato Gel (Ingenol Mebutate) Market Size To Worth USD 1121.07 Million By 2033 | CAGR of 8.28%
Category: HealthcareGlobal Picato Gel (Ingenol Mebutate) Market Size To Worth USD 1121.07 Million By 2033
According to a research report published by Spherical Insights & Consulting, the Global Picato Gel (Ingenol Mebutate) Market Size is Expected to Grow from USD 506.23 Million in 2023 to USD 1121.07 Million By 2033, at a CAGR of 8.28% during the Forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 250 pages with 120 Market data tables and figures & charts from the report on the "Global Picato Gel (Ingenol Mebutate) Market Size, Share, and COVID-19 Impact Analysis, By Product Type (0.015% and 0.05%), By Indications (Skin Cancer, Actinic Keratosis, and Others), By Distribution Channel (Online Pharmacies, Hospitals, Dermatology Clinics, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/picato-gel-ingenol-mebutate-market
The picato gel market focuses on the development, formulation, and commercialization of picato gel containing ingenol mebutate as an active pharmaceutical ingredient for treating actinic keratosis. Ingenol mebutate, obtained from Euphoria peplus, is a well-tolerated treatment for actinic keratosis due to its short treatment period and good patient adherence. The market growth is driven by the increasing prevalence rate of actinic keratosis, a common dermatological condition with an estimated 13.3% prevalence in the European population. The disease is caused by prolonged exposure to UV radiation and other risk factors, with AKs being more prevalent in the head and upper extremities. The global prevalence rate of 14% indicates a significant disease burden. The rising demand for topical treatments for actinic keratosis is driven by the growing cases among the worldwide population and the increasing demand for topical treatments. Almirall's "Stay Vigilant" campaign aims to raise awareness about the disease and its relationship with prolonged exposure to sunlight. However, the high price of the picato gel may impede the growth of the market.
The 0.015% segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the product type, the global picato gel (ingenol mebutate) market is categorized into 0.015% and 0.05%. Among these, the 0.015% segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period. This is attributed to targeted treatment, increasing geriatric population, actinic keratosis prevalence, minimal systemic absorption, and enhanced patient compliance.
The actinic keratosis segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the indications, the global picato gel (ingenol mebutate) market is categorized as skin cancer, actinic keratosis, and others. Among these, the actinic keratosis segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. This is ascribed to the rising incidence of actinic keratosis, which is more prevalent in individuals with prolonged UV radiation exposure, genetic predisposition, and low immunity.
The hospitals segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the distribution channel, the global picato gel (ingenol mebutate) market is categorized as online pharmacies, hospitals, dermatology clinics, and others. Among these, the hospitals segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. This is driven by increasing in-patient and outpatient services, dermatologist availability, geriatric population admission, collaboration between private and government hospitals, and healthcare policy provisions.
North America is expected to hold the greatest share of the global picato gel (ingenol mebutate) market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global picato gel (ingenol mebutate) market over the forecast period. This is attributed to the high occurrence of skin disorders and the established healthcare infrastructure, especially in the United States, where actinic keratosis and skin cancer are common. The market grows due to the region's intense emphasis on research and pharmaceutical firms. Canada and Mexico exhibit consistent growth owing to the advancement of healthcare infrastructure and heightened awareness of skin disorders.
Asia Pacific is predicted to grow at the fastest CAGR throughout the estimated period. This is owing to rising disposable incomes, improved healthcare infrastructure, and increased skin health awareness. China and India are emerging as significant markets, with government initiatives supporting growth. The rising prevalence of actinic keratosis and early skin cancer prevention drive demand, while innovations in topical formulations and improved healthcare infrastructure enhance the appeal of products like picato gel.
Major key players in the global picato gel (ingenol mebutate) market are Sun Pharmaceutical Industries Ltd., Sanofi S.A., GlaxoSmithKline plc, Novartis AG, AbbVie Inc., Valeant Pharmaceuticals International, Inc., Roche Holdings AG, Allergan plc, Leo Pharma, Teva Pharmaceutical Industries Ltd., Galderma S.A., AstraZeneca plc, Pfizer Inc., Bayer AG, and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global picato gel (ingenol mebutate) market based on the below-mentioned segments:
Global Picato Gel (Ingenol Mebutate) Market, By Product Type
- 0.015%
- 0.05%
Global Picato Gel (Ingenol Mebutate) Market, By Indications
- Skin Cancer
- Actinic Keratosis
- Others
Global Picato Gel (Ingenol Mebutate) Market, By Distribution Channel
- Online Pharmacies
- Hospitals
- Dermatology Clinics
- Others
Global Picato Gel (Ingenol Mebutate) Market, By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?